Rega saham Aethlon Medical (AEMD)

This daily price chart on the GURU.Markets platform illustrates the financial model of Aethlon Medical (AEMD), which is based on the expenditure of research investments without current sales, where the indicator stands at 5.12. The risks of narrow specialization in blood filters are offset by prospects in oncology. The innovative Hemopurifier device physically removes pathogens from the bloodstream, becoming a critical solution for severe infections.

The market price represents the current value of a single share, reflecting investors' aggregate valuation of all future cash flows and risks associated with the issuer. Analyzing market price fluctuations reveals how the slow regulatory approval of blood filtration systems increases operating expenses for Aethlon Medical (AEMD), which directly limits capitalization growth due to low business scaling efficiency.